The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Rain Therapeutics Inc. announced a clinical supply agreement with Roche for the supply of the anti-Programmed Death Ligand-1 (PD-L1) monoclonal ...
read more
Covis Pharma Group announced that Covis Pharma GmbH has completed the acquisition of Eklira® (aclidinium bromide), known as Tudorza® in the US and ...
read more
NRx Pharmaceuticals has submitted an application for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA) for the use of ...
read more
Samsung Bioepis Co., Ltd. and Organon & Co. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental ...
read more
Thursday, January 13, 2022
AstraZeneca has signed a collaboration agreement with Scorpion Therapeutics to discover, develop and commercialize precision medicines against ...
read more
Thursday, January 13, 2022
Adare Pharma Solutions, a global, technology-driven contract development and manufacturing organization (CDMO), announced the appointment of Tom ...
read more
Tuesday, January 18, 2022
Protagen Protein Services GmbH, BioAnalytix, Inc., and GeneWerk GmbH announced their unified operations and re-brand as ProtaGene, a CRO partner for ...
read more
Wednesday, January 19, 2022
Endo International announced that it and its wholly-owned subsidiaries Endo Pharmaceuticals Inc. and Endo Health Solutions Inc. have entered into a ...
read more
Wednesday, January 19, 2022
Merck and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement with the United Nations Children’s Fund (UNICEF) to ...
read more
Wednesday, January 19, 2022
Regeneron Pharmaceuticals, Inc. announced the FDA acceptance to review the supplemental Biologics License Application (sBLA) for PD-1 inhibitor ...
read more
FDA-TRACK is releasing the latest annual User Fee Program data for animal and human drug and biosimilar products. Final review performance results for...
read more
Karyopharm Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for eltanexor, a novel ...
read more
Lantern Pharma announced that the U.S. Food and Drug Administration (FDA) has granted both Rare Pediatric Disease Designation and Orphan Drug ...
read more
Tuesday, January 25, 2022
Merck announced that the FDA has issued a Complete Response Letter (CRL) regarding the NDA for gefapixant, the investigational, non-narcotic, orally ...
read more
Wednesday, January 26, 2022
In light of the most recent information and data available, the FDA revised the authorizations for two monoclonal antibody treatments – bamlanivimab ...
read more